ArticleLeukemia2026

Unraveling cellular and molecular mechanisms of relapse in CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

Jiaqi Tan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.